SG Americas Securities’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Sell |
8,342
-20,289
| -71% | -$469K | ﹤0.01% | 2036 |
|
|
2025
Q1 | $773K | Buy |
+28,631
| New | +$773K | ﹤0.01% | 1258 |
|
|
2024
Q4 | – | Sell |
-5,738
| Closed | -$261K | – | 2899 |
|
|
2024
Q3 | $261K | Sell |
5,738
-28,926
| -83% | -$1.32M | ﹤0.01% | 2004 |
|
|
2024
Q2 | $1.45M | Buy |
+34,664
| New | +$1.45M | 0.01% | 1034 |
|
|
2024
Q1 | – | Sell |
-9,345
| Closed | -$100K | – | 2788 |
|
|
2023
Q4 | $100K | Buy |
+9,345
| New | +$100K | ﹤0.01% | 2532 |
|
|
2023
Q1 | – | Sell |
-7,902
| Closed | -$104K | – | 3063 |
|
|
2022
Q4 | $104K | Buy |
+7,902
| New | +$104K | ﹤0.01% | 2448 |
|
|
2021
Q4 | – | Sell |
-65,414
| Closed | -$1.42M | – | 3159 |
|
|
2021
Q3 | $1.42M | Buy |
+65,414
| New | +$1.42M | 0.01% | 1454 |
|